The surge in coronavirus patients never arrived, so L.A. Surge Hospital will close its doors in June.
The goal to more fully reopen in the next six weeks comes as Los Angeles County reports 76 new deaths related to COVID-19 and more than 1,100 new cases.Dr. Patrick Soon-Shiong, who owns The Times, purchased St. Vincent for $135 million in a deal that was finalized in early April. His global health firm NantWorks is a creditor in Verity’s bankruptcy proceedings.
The state’s lease was transferred to Soon-Shiong, but he was not involved in the operation of the surge hospital.The state had initially anticipated needing 50,000 hospital beds for COVID-19 patients. Hospitals began to execute “surge plans” that would add 30,000 beds to their count. The rest would come from medical centers like St. Vincent and Seton Medical Center in the Bay Area, as well as field medical stations set up at convention centers and fairgrounds, and the U.S.
At its peak, the Los Angeles Surge Hospital employed nearly 500 personnel, from doctors and nurses to administrators and support staff. Many worked at the hospital while continuing to serve patients in other facilities throughout Southern California. Soon-Shiong said at the time he purchased St. Vincent Medical Center that he planned to use buildings on the 10-acre campus for COVID-19 research.
Seton Medical Center, which has been exclusively treating COVID-19 patients, is also ending its agreement with the state.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ryanair shares surge on reduced cash burn, optimistic outlookRyanair shares surged 15% on Monday after Europe's largest low-cost carrier announced details of sharp cost cuts and promised a swift return to full capacity and expansion in the aftermath of the COVID-19 crisis.
Read more »
Walmart Earnings: U.S. sales jump 10%, boosted by 74% surge in online buying amid coronavirusThe world's largest retailer was a go-to destination as consumers stocked up during the pandemic.
Read more »
Moderna reports 'positive' data on early-stage coronavirus vaccine trial, shares surge 39%Moderna's early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, sending the company's shares surging.
Read more »